This report from Richard Sears has been published by Mad in America. It begins:
“A new article published in JAMA Psychiatry finds that mindfulness based stress reduction (MBSR) is as effective in treating anxiety disorders as the antidepressant escitalopram.
According to the current research by Elizabeth Hoge from Georgetown University, MBSR is safer and has fewer adverse effects than escitalopram. The authors write:
‘Our prospective randomized clinical trial found that MBSR was noninferior to escitalopram for the treatment of anxiety disorders. In addition, MBSR was safe and well tolerated, with fewer adverse events associated with treatment compared with escitalopram.‘
The goal of the current research was to compare an mindfulness program to the antidepressant escitalopram for the treatment of anxiety disorders. The researchers recruited 276 participants from Boston, New York, and Washington, D.C. hospitals to accomplish this goal. To be eligible for the study, participants had to be between 18 and 75 years old and have a primary diagnosis of generalized anxiety disorder, social anxiety disorder, panic disorder, or agoraphobia …”
You can read more from here.